用于基因治疗制造 2.0的现成技术工艺
用于基因治疗制造 2.0的现成技术工艺
Repligen is ready to partner with gene therapy developers and manufacturers, providing technology breakthroughs and high impact solutions for plasmid and viral vector manufacturing. May 12, 2020 | 11 minutes
12年5月
Discover More Webinars
01
02
03
04
05
01
/
05
网络研讨会
Automating the UF/DF Process with In-Line Concentration Measurement to Reduce Cycling Time and Accelerate PD
8年5月
网络研讨会
Innovative, differentiated technologies advancing new modalities: Case studies in mRNA & viral vectors
Feb 23
网络研讨会
网络研讨会
Accelerate your UF/DF process using the only in-line concentration controlled TFF system
Feb 9
网络研讨会
Disruptive technologies transforming upstream process intensification for all modalities
Feb 2
11:00 EDT